In Vitro Killing of Community-Associated Methicillin-Resistant Staphylococcus aureus with Drug Combinations

AUTOR(ES)

Shelburne, Samuel A.

FONTE

American Society for Microbiology

RESUMO

This study employs time-kill techniques to examine the most common drug combinations used in the therapy of methicillin-resistant Staphylococcus aureus (MRSA) infections, vancomycin plus either gentamicin or rifampin. Community-associated MRSA were more likely to be synergistically inhibited by combinations of vancomycin and gentamicin versus vancomycin alone compared to inhibition associated with hospital-acquired strains.

Documentos Relacionados

• Community-associated methicillin-resistant Staphylococcus aureus in non-outbreak skin infections
• Emergence and Spread of Community-Associated Methicillin-Resistant Staphylococcus aureus in Rural Wisconsin, 1989 to 1999
• Recurrent Community-Associated Methicillin-Resistant Staphylococcus aureus Infections among HIV-Infected Persons: Incidence and Risk Factors
• Molecular Characteristics of Nosocomial and Native American Community-Associated Methicillin-Resistant Staphylococcus aureus Clones from Rural Wisconsin
• Community-Associated Methicillin-Resistant Staphylococcus aureus: Trends in Case and Isolate Characteristics from Six Years of Prospective Surveillance